SVG Sprites

Press

Press Releases 12.18.2019

Statement from Margarida Jorge on President Trump’s proposal to allow importation of some prescription drugs.

“President Trump’s proposal to import prescription drugs is a poor substitute for real reforms that would guarantee everyone affordable medicine and stop Big Pharma’s price gouging. Instead, Trump’s plan does nothing to fix our fundamentally flawed system.”

LDPN in the News 12.16.2019

High prescription costs are just one way the Big Pharma drug companies rip us off

By Margarida Jorge and Frank Clemente

The newly passed House bill allowing Medicare negotiations on drug prices is a first step toward taming Big Pharma and broader corporate abuse.

Last week’s House vote to rein in skyrocketing prescription drug prices was overdue. Now it’s up to the Senate and President Donald Trump to take action.

Press Releases 12.12.2019

Statement from Margarida Jorge, Campaign Director, Lower Drug Prices Now, on the passage of HR3 in the US House of Representatives:

Today’s bipartisan vote to pass the Elijah E. Cummings Lower Drug Prices Now Act is a critical step in helping more patients get the prescription drugs they need to be healthy. For the first time ever, this law would give the government the power to negotiate lower drug prices for millions of seniors and people with disabilities covered by Medicare and people with private insurance coverage.

LDPN in the News 12.12.2019

Drug pricing legislation will save lives

By BEN JEALOUS

If enacted, H.R. 3, the Elijah E. Cummings Lower Drug Prices Now Act, would, for the first time, give the government the power to negotiate lower drug prices for millions of patients enrolled in Medicare, and millions more with private insurance. The stakes are huge: Not only would this save Medicare $500 billion over the next decade, these savings would be used to expand benefits to include dental, vision and hearing coverage and help low-income seniors pay out-of-pocket costs.

LDPN in the News 11.25.2019

NJ drug manufacturers rake in profits while patients struggle to afford their insulin | Opinion

By ROBIN TANNER

My mother is one of the 7.4 million Americans who depend on insulin to manage their diabetes.

With insulin prices nearly doubling from 2012 to 2016, my family and millions of others have been forced to cut corners to afford their life-saving medication, all while drug corporations have raked in billions in profits, including two companies based right here in our state.

LDPN in the News 11.20.2019

Commentary: Congress has an opportunity to lower drug costs – and there’s no time to waste

BY SARA EWING-MERRILLSPECIAL TO THE PRESS HERALD

People who take insulin are among those hardest hit by spiraling expenses. A new medication pricing bill would help them.

Americans agree that prescription drug prices are too high. Countless individuals and families across the country are grappling with impossible choices between buying the medication they need to stay healthy and paying the bills. And with no prescription is that truer than insulin.

LDPN in the News 11.17.2019

For diabetics, passage of drug-cost bill is intensely personal | Opinion

BY MITCH LENETT

Amid the ongoing health care debate in Washington, the House of Representatives will soon consider game-changing legislation that would provide relief to the American public from the high costs of prescription drugs.

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles